胃切除的非肥胖糖尿病Goto-Kakizaki大鼠中优势肠道普雷沃氏菌Prevotella copri通过增强FXR信号改善葡萄糖稳态
在Goto-Kakizaki(GK)非肥胖自发性2型糖尿病大鼠中,垂直袖状胃切除术(VSG)导致葡萄糖耐量永久改善,伴随盲肠Prevotella copri显著富集。通过抗生素、接种胃切除GK大鼠肠道菌群或直接接种P. copri,均可显著改善葡萄糖耐量且不依赖体重变化;接种后血浆胆汁酸升高,肝脏糖原增加,Fxr、Srebf1c、Chrebp和Il10表达上调,Cyp7a1表达下调。
要点
- VSG在GK大鼠中导致葡萄糖耐量永久改善,盲肠P. copri显著富集。
- 通过抗生素或接种P. copri可改善葡萄糖耐量,不依赖体重变化。
- P. copri接种升高血浆胆汁酸,上调肝脏Fxr信号并下调Cyp7a1。
核心结论
- 肠道P. copri通过增强胆汁酸代谢和法尼醇X受体(FXR)信号改善葡萄糖稳态,可能为2型糖尿病新疗法提供机会。
研究设计与样本
- 在Goto-Kakizaki(GK)非肥胖自发性2型糖尿病大鼠中进行垂直袖状胃切除术(VSG)后分析肠道菌群,随后在GK大鼠中进行生理学研究。
主要发现
- VSG在GK大鼠中导致葡萄糖耐量永久改善,伴随肠道菌群微小变化,主要以盲肠Prevotella copri显著富集为特征。
- 通过允许性抗生素治疗、接种胃切除GK大鼠的肠道菌群以及直接接种P. copri,使GK大鼠肠道菌群富集P. copri,均导致葡萄糖耐量显著改善,且不依赖体重变化。
- 接种P. copri以及来自VSG治疗大鼠的P. copri富集菌群后,GK大鼠血浆胆汁酸升高;接种的GK大鼠肝脏糖原增加,Fxr(又称Nr1h4)、Srebf1c、Chrebp(又称Mlxipl)和Il10表达上调,Cyp7a1表达下调。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Drug and surgical-based therapies in type 2 diabetes are associated with altered gut microbiota architecture. Here we investigated the role of the gut microbiome in improved glucose homeostasis following bariatric surgery. METHODS: We carried out gut microbiome analyses in gastrectomised (by vertical sleeve gastrectomy [VSG]) rats of the Goto-Kakizaki (GK) non-obese model of spontaneously occurring type 2 diabetes, followed by physiological studies in the GK rat. RESULTS: VSG in the GK rat led to permanent improvement of glucose tolerance associated with minor changes in the gut microbiome, mostly characterised by significant enrichment of caecal Prevotella copri. Gut microbiota enrichment with P. copri in GK rats through permissive antibiotic treatment, inoculation of gut microbiota isolated from gastrectomised GK rats, and direct inoculation of P. copri, resulted in significant improvement of glucose tolerance, independent of changes in body weight. Plasma bile acids were increased in GK rats following inoculation with P. copri and P. copri-enriched microbiota from VSG-treated rats; the inoculated GK rats then showed increased liver glycogen and upregulated expression of Fxr (also known as Nr1h4), Srebf1c, Chrebp (also known as Mlxipl) and Il10 and downregulated expression of Cyp7a1. CONCLUSIONS: Our data underline the impact of intestinal P. copri on improved glucose homeostasis through enhanced bile acid metabolism and farnesoid X receptor (FXR) signalling, which may represent a promising opportunity for novel type 2 diabetes therapeutics.
引用
- Péan N, Le Lay A, Brial F, et al. Dominant gut Prevotella copri in gastrectomised non-obese diabetic Goto-Kakizaki rats improves glucose homeostasis through enhanced FXR signalling. Diabetologia. 2020. PMID: 32173762. doi:10.1007/s00125-020-05122-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。